ImmunityBio (IBRX) FCF Margin Growth (1y) (2015 - 2026)
ImmunityBio (IBRX) FCF Margin Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,187.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,525.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -341.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | ImmunityBio | 7.60 Bn | 7.22 Bn | 43.97 Mn | 34,716.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 34,716.00 |
| Dec 31, 2025 | 89,305.00 |
| Sep 30, 2025 | 143,700.00 |
| Jun 30, 2025 | 943,956.00 |
| Mar 31, 2025 | 27.01 Mn |
| Dec 31, 2024 | 7.27 Mn |
| Sep 30, 2024 | 9.76 Mn |
| Jun 30, 2024 | 17.97 Mn |
| Mar 31, 2024 | -24.19 Mn |
| Dec 31, 2023 | 7.64 Mn |
| Sep 30, 2023 | -1.74 Mn |
| Jun 30, 2023 | 19.52 Mn |
| Mar 31, 2023 | 50.58 Mn |
| Dec 31, 2022 | -13.21 Mn |
| Sep 30, 2022 | 2.93 Mn |
| Jun 30, 2022 | -36.42 Mn |
| Mar 31, 2022 | -48.79 Mn |
| Dec 31, 2021 | 24.81 Mn |
| Sep 30, 2021 | -8.67 Mn |
| Jun 30, 2021 | -949,499.00 |